RBI argued that since significant value destruction may have already happened in stressed assets, a comparison of realised value with admitted claims may not be a reasonable indicator of the effectiveness of the resolution process.
Molbio Diagnostics collects Rs 281 cr from anchor investors ahead of IPO
Molbio Diagnostics has successfully attracted Rs 281.5 crore from anchor investors ahead of its much-anticipated initial public offering. The company aims to raise between Rs